For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

GSK PLC GSK shares rose 1.06% to £13.34 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

Shares of GSK PLC GSK inched down 0.75% to £13.20 Monday, on what proved to be an all-around grim trading session for the ...

British drugmaker GSK said on Monday its experimental cancer drug Blenrep in combination with other treatments reduced the ...

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

Analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of GSK in a research note issued to investors on ...

GSK has handed over $45 million upfront to fellow London-based firm Relation to help the pharma identify new targets for ...

Based on DREAMM-7 and another positive phase 3 trial, DREAMM-8 for Blenrep’s combination with Bristol Myers Squibb’s Pomalyst ...

GSK (GSK) announced that the European Medicines Agency, EMA, has granted Priority Medicines, PRIME, Designation for GSK5764227, its ...

GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding ...

Short GSK slightly under 34.74, target n/a, stop loss @ 34.84 Check the time stamp on this data. Updated AI-Generated Signals ...